In vivo efficacy of curcumin and curcumin nanoparticle in trypanosoma congolense, broden 1904 (kinetoplastea: trypanosomatidae)-infected mice

Simple item page
dc.contributor.authorMolefe-Nyembe, Nthatisi Innocentia
dc.contributor.authorAdeyemi, Oluyomi Stephen
dc.contributor.authorKondoh, Daisuke
dc.contributor.authorKato, Kentaro
dc.contributor.authorInoue, Noboru
dc.date.accessioned2023-11-06T14:31:45Z
dc.date.available2023-11-06T14:31:45Z
dc.date.issued2023
dc.description.abstractCurcumin (CUR) is known for its wide folkloric effects on various infections; however, its solubility status has remained a hindrance to its bioavailability in the host. This study evaluated the comparative effects of CUR and CUR-nanoparticle in vitro on T. congolense, T. b. brucei, and T. evansi. Additionally, CUR and CUR-nanoparticle anti-Trypanosoma efficacy were assessed in vivo against T. congolense. All the CUR-nanoparticles were two folds more effective on the T. congolense as compared to CUR in vitro, with recorded efficacy of 3.67 ± 0.31; 7.61 ± 1.22; and 6.40 ± 3.07 μM, while the CUR-nanoparticles efficacy was 1.56 ± 0.50; 28.16 ± 9.43 and 13.12 ± 0.13 μM on T. congolense, T. b. brucei, and T. evansi, respectively. Both CUR and CUR-nanoparticles displayed moderate efficacy orally. The efficacy of CUR and CUR-nanoparticles in vivo was influenced by solubility, presence of food, and treatment period. CUR-treated mice were not cured of the infection; however, the survival rate of the orally treated mice was significantly prolonged as compared with intraperitoneal-treated mice. CUR-nanoparticles resulted in significant suppression of parasitemia even though relapsed was observed. In conclusion, CUR and CUR-nanoparticles possess moderate efficacy orally on the trypanosomes as compared to the intraperitoneal treatment.
dc.description.versionPublisher's version
dc.identifier.citationMolefe-Nyembe, N. I., Adeyemi, O. S., Kondoh, D., Kato, K., Inoue, N., & Suganuma, K. (2023). In vivo efficacy of curcumin and curcumin nanoparticle in trypanosoma congolense, broden 1904 (kinetoplastea: trypanosomatidae)-infected mice. Pathogens, 12(10), 1227. https://doi.org/10.3390/pathogens12101227
dc.identifier.issn2076-0817 (online)
dc.identifier.urihttps://doi.org/10.3390/pathogens12101227
dc.identifier.urihttp://hdl.handle.net/11660/12329
dc.language.isoen
dc.publisherMDPI
dc.rights.holderAuthor(s)
dc.rights.licensehttps://www.mdpi.com/about/openaccess
dc.subjectanimal African trypanosomosis
dc.subjectdrug discovery
dc.subjectnanomedicine
dc.subjectnatural products
dc.subjectphytomedicine
dc.titleIn vivo efficacy of curcumin and curcumin nanoparticle in trypanosoma congolense, broden 1904 (kinetoplastea: trypanosomatidae)-infected mice
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Molefe-Nyembe_In vivo efficacy of curcumin_2023.pdf
Size:
11.01 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.63 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Research Articles (Zoology and Entomology)